Inter Pharma PCL (BKK:IP)

Market Cap	2.43B
Revenue (ttm)	2.05B
Net Income (ttm)	72.22M
Shares Out	605.34M
EPS (ttm)	0.12
PE Ratio	33.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185,952
Average Volume	452,660
Open	4.020
Previous Close	4.020
Day's Range	3.960 - 4.020
52-Week Range	2.020 - 4.540
Beta	0.58
RSI	56.46
Earnings Date	Nov 11, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.